Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia

Authors not listed

Merck Sharp & Dohme LLC · 2007

Dysbiosis Human Randomized controlled trial

＋ Sign in to save

Abstract

A study to evaluate the safety, tolerability, and efficacy of MK-0773 in women with sarcopenia (loss of muscle mass).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-12 MST

Cite this

APA

Anonymous. (2007). A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia. <em>Merck Sharp & Dohme LLC</em>. https://clinicaltrials.gov/study/NCT00529659

Vancouver

Anonymous. A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia. Merck Sharp & Dohme LLC. 2007.

BibTeX

@misc{anon2007APhase, title = {A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia}, author = {Anonymous}, journal = {Merck Sharp & Dohme LLC}, year = {2007}, }